|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter
467
|
Wed, 8/1/07, 2:00 PM - 3:50 PM | CC-255 A |
| Bayesian Approaches to Clinical Trials - Topic Contributed - Papers | ||
|
Section on Bayesian Statistical Science, Biopharmaceutical Section |
||
| Organizer(s): Pulak Ghosh, Georgia State University | ||
| Chair(s): Peter F. Thall, The University of Texas M.D. Anderson Cancer Center | ||
| 2:05 PM |
Monitoring Late Onset Toxicities in Phase I Trials Using Predicted Risks —  Benjamin N. Bekele, The University of Texas M.D. Anderson Cancer Center
|
|
| 2:25 PM |
Decision Analysis in Support of Clinical Trial Protocol Decisions — Joseph Kahn, Novartis Pharmaceuticals
|
|
| 2:45 PM |
Could Bayesians and Frequentists Agree When Designing Clinical Trials? — Lurdes Inoue, University of Washington
|
|
| 3:05 PM |
Bayesian Optimal Design in Phase II Studies — Gary Rosner, The University of Texas M. D. Anderson Cancer Center; Peter Mueller, The University of Texas M.D. Anderson Cancer Center; Meichun Ding, Amgen Inc.
|
|
| 3:25 PM |
Incorporating Patient's Characteristics in Cancer Phase I Clinical Trials Using Escalation with Overdose Control — Mourad Tighiouart, Emory University; André Rogatko, Emory University; Zhiheng Xu, Emory University
|
|
| 3:45 PM | Floor Discussion | |
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |